EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands; Department of General Practice and Elderly Care Medicine, VU University Medical Center, Amsterdam, The Netherlands.
EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands; Department of General Practice and Elderly Care Medicine, VU University Medical Center, Amsterdam, The Netherlands.
J Am Med Dir Assoc. 2016 Feb;17(2):128-35. doi: 10.1016/j.jamda.2015.08.010. Epub 2015 Sep 26.
To describe observations of suffering in patients with dementia from the diagnosis of pneumonia until cure or death.
Prospective observational study between January 2012 and May 2014.
Dutch nursing homes (32).
Nursing home patients with dementia and pneumonia (n = 193).
Independent observers performed observations of patients with dementia scheduled 13 times within the 15 days following diagnosis of pneumonia; twice daily in the first 2 days- to observe discomfort (Discomfort Scale-Dementia of Alzheimer Type; range 0-27), comfort (End Of Life in Dementia-Comfort Assessment in Dying; range 14-42), pain (Pain Assessment in Advanced Dementia; range 0-10), and dyspnea (Respiratory Distress Observation Scale; range 0-16).
Observational data were obtained for 208 cases of pneumonia in 193 patients. In 71.2% of cases, patients received 1 or more treatments to relieve symptoms such as antipyretics, opioids, or oxygen; 89.4% received antibiotics. Discomfort was highest 1 day after diagnosis [mean Discomfort Scale-Dementia of Alzheimer Type score 8.1 (standard deviation, SD 5.8)], then declined, and stabilized around day 10 [mean 4.5 (SD 4.1)], or increased in the days preceding death. Observed pain and dyspnea followed a comparable pattern. Discomfort patterns did not differ much between cases treated with and without antibiotics.
Pneumonia in patients with dementia involved elevated levels of suffering during 10 days following diagnosis and in the days preceding death. Overall observed discomfort was low compared with prior Dutch studies, and the number of treatments to relieve symptoms was higher. Future studies should examine whether symptoms of pneumonia can be relieved even more, and what treatments are the most effective.
描述从诊断为肺炎到治愈或死亡的痴呆症患者的痛苦观察结果。
2012 年 1 月至 2014 年 5 月期间的前瞻性观察研究。
荷兰养老院(32 个)。
患有痴呆症和肺炎的养老院患者(n=193)。
在肺炎诊断后 15 天内,安排 13 次独立观察者对患有痴呆症的患者进行观察;前 2 天每天观察两次,以观察不适(阿尔茨海默病痴呆症不适量表;范围 0-27)、舒适(痴呆末期舒适评估;范围 14-42)、疼痛(晚期痴呆症疼痛评估;范围 0-10)和呼吸困难(呼吸窘迫观察量表;范围 0-16)。
在 193 名患者中,对 208 例肺炎病例获得了观察数据。在 71.2%的病例中,患者接受了 1 种或多种治疗以缓解症状,如退热剂、阿片类药物或氧气;89.4%接受了抗生素治疗。诊断后第 1 天不适程度最高[平均阿尔茨海默病痴呆症不适量表评分 8.1(标准差 5.8)],然后下降,并在第 10 天左右稳定下来,或在死亡前几天增加。观察到的疼痛和呼吸困难也呈现出类似的模式。接受和未接受抗生素治疗的病例之间,不适模式差异不大。
痴呆症患者的肺炎在诊断后 10 天内以及死亡前几天,涉及到更高水平的痛苦。与之前的荷兰研究相比,总体观察到的不适程度较低,缓解症状的治疗次数更多。未来的研究应该研究是否可以更有效地缓解肺炎症状,以及哪些治疗最有效。